BioClean P-Zero™ - Excellent Cytotoxic Protection
Part of the BioClean Chemo Safety Wear range BioClean P-Zero? sterile cleanroom gloves are made from polychloroprene, provide exceptional cytotoxic protection, are antistatic and have outstanding tactility and grip.
BioClean P-Zero™ - Excellent Cytotoxic Protection
BioClean P-Zero™ (BPZS) sterile gloves provide exceptional cytotoxic protection, are antistatic and have outstanding tactility and grip.
The BioClean™ Chemo Safety Wear range, the P-Zero are hand-specific 300mm (12”) latex-free, powder-free, natural-coloured gloves featuring a textured surface and beaded cuff for strength and stability on the wrist. Packed in a non-particulating EasyTear™ pouch, they are ISO Class 4 and EU GMP Grade A compatible and available in sizes 6.0 to 9.0 (including half sizes.)
All BioClean Chemo Safety Wear gloves are tested against the most stringent standard ASTM D6978-05 (standard practice for assessment of resistance of medical gloves to permeation by chemotherapy drugs) which is 100 times more stringent than its European counterpart EN 374-3:2003, meaning BioClean P-Zero gloves are the safe choice to make.
Contact Details:
Nitritex Ltd
Minton Enterprise Park, Oaks Drive
Newmarket, Suffolk, CB8 7YY
www.bioclean.cominfo@bioclean.comTel: +44 1638 663338
Transformations in Drug Development for Cell and Gene Therapies
March 28th 2025As a recognized leader in immunophenotyping for clinical trials, Kevin Lang from PPD discusses how spectral flow cytometry is transforming drug development, particularly in cell and gene therapies like CAR-T. He also dives into his award-winning research, including his 2024 WRIB Poster Award-winning work, and his insights from presenting at AAPS PharmSci360.
Advancing Clinical Trials with Spectral Flow Cytometry: A Conversation with Kevin Lang
March 28th 2025As a recognized leader in immunophenotyping for clinical trials, Kevin Lang from PPD discusses how spectral flow cytometry is transforming drug development, particularly in cell and gene therapies like CAR-T. He also dives into his award-winning research, including his 2024 WRIB Poster Award-winning work, and his insights from presenting at AAPS PharmSci360.
Understanding the Variability in Bioburden Test Results in Biomanufacturing
May 7th 2025This article explores the impact of test volume, microbial distribution, and dilution errors on bioburden testing variability. It presents statistical approaches to estimate percentage error and discusses strategies to optimize microbial enumeration techniques in biopharmaceutical quality control.
